Generate Biomedicines, Inc. (GENB)
17.71
+1.59
(+9.86%)
USD |
NASDAQ |
Aug 24, 16:00
17.62
-0.09
(-0.51%)
After-Hours: 20:00
Generate Biomedicines Debt to Equity Ratio : 0.1373 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1373 |
| Date | Value |
|---|---|
| March 31, 2026 | 0.1274 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Twist Bioscience Corp. | 0.21 |
| Prime Medicine, Inc. | 2.825 |
| Intellia Therapeutics, Inc. | 0.1009 |
| Beam Therapeutics, Inc. | 0.2317 |
| Moderna, Inc. | 0.1904 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 561.69M |
| Total Liabilities (Quarterly) | 105.64M |
| Shareholders Equity (Quarterly) | 456.04M |
| Current Ratio | 8.303 |
| Net Debt Paydown Yield | -0.47% |